Genelux GNLX
NASDAQ GNLX
$2.48 -0.04 (-1.59%)
At close: Sep 10, 2026 · 4:00 PM EDT

Genelux (GNLX) Revenue (2022 - 2024)

Genelux (GNLX) posted Revenue of $8000.0 for Q1 2024, down 95.29% on a QoQ basis from $170000.0 in Q1 2023, and down 95.29% year-over-year from $170000.0 in Q2 2023.

Analysis

Genelux (GNLX) Revenue (2022 - 2024) Analysis & Trends

Genelux has reported Revenue for 3 years, with the latest figure at $8000.0 in Q1 2024.

  • On a quarterly basis, Revenue fell 95.29% year-over-year to $8000.0 in Q1 2024; TTM through Dec 2024 was $8000.0, a 95.29% decrease from a year earlier, with the FY2025 full-year figure at $8000.0, changed 0.0% from the prior year.
  • Revenue was $8000.0 for Q1 2024 at Genelux, down from $170000.0 in the prior quarter.
  • The five-year high for Revenue was $11.0 million in Q3 2022, with the low at $8000.0 in Q1 2024.
  • Average Revenue over 3 years is $2.8 million, with a median of $119000.0 recorded in 2022.
  • The largest YoY upside for Revenue was 95.29% in 2024 against a maximum downside of 95.29% in 2024.
  • Over 3 years, Revenue stood at $68000.0 in 2022, then surged by 150.0% to $170000.0 in 2023, then sank by 95.29% to $8000.0 in 2024.
  • The last three Revenue figures came in at $8000.0 (Q1 2024), $170000.0 (Q1 2023), and $68000.0 (Q4 2022), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Revenue (Qtr)
1 Amgen 206.44 Bn 192.45 Bn 7.24 Bn 10.05 Bn
2 Gilead Sciences 179.97 Bn 176.79 Bn 6.22 Bn 7.80 Bn
3 Vertex Pharmaceuticals 130.57 Bn 122.72 Bn 2.84 Bn 3.33 Bn
4 Regeneron Pharmaceuticals 81.63 Bn 73.63 Bn 3.93 Bn 4.29 Bn
5 Argenx Se 60.34 Bn 55.16 Bn 1.37 Bn 1.52 Bn
6 Moderna 54.37 Bn 49.23 Bn 52.00 Mn 145.00 Mn
7 Alnylam Pharmaceuticals 33.07 Bn 29.76 Bn 992.69 Mn 1.29 Bn
8 Biogen 31.84 Bn 30.55 Bn 1.96 Bn 2.74 Bn
9 Roivant Sciences 29.49 Bn 29.49 Bn 1.16 Mn 1.44 Mn
10 Genelux 108.17 Mn 108.17 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2024 8,000.00
Mar 31, 2023 170,000.00
Dec 31, 2022 68,000.00
Sep 30, 2022 11.00 Mn